The transcriptional activation of β-catenin downstream targets, including MMP-9, Myc, Axin2, and cyclin D1, is able to promote cell cycle progression, cell proliferation, and metastasis in the progression of cancer [10–12]. This evidence concerns the gene MYC and cancer.